FDA Adverse Event Injury Summary report: N

OMNIPOD 5 CONTROLLER

MDR report key: 18993186 · Received March 28, 2024

Report

Report Number
3004464228-2024-11088
Event Type
Injury
Date Received
March 28, 2024
Date of Event
March 20, 2024
Report Date
April 8, 2024
Manufacturer
INSULET CORPORATION
Product Code
QFG
UDI-DI
10385083000022
PMA / PMN Number
K203768
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

ADD TO EMDR-181260. HEALTH EFFECT - CLINICAL CODE = E1206 HYPOGLYCEMIA.

Additional Manufacturer Narrative · 0

ACCORDING TO THE COMPLAINANT THE DEVICE WILL NOT BE RETURNED FOR INVESTIGATION. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION AND HYPOGLYCEMIA. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT'S BLOOD GLUCOSE (BG) VALUES DROPPED TO LESS THAN 40 MG/DL. THE PATIENT WOULD NOT WAKE UP. THE PARAMEDICS SHOWED UP TO RENDER HELP. FOR TREATMENT, THE PATIENT WAS GIVEN GLUCOSE. NO FURTHER DETAILS WERE GIVEN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1370146 OMNIPOD 5 CONTROLLER ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG INSULET CORPORATION PT-000409 H000521 10385083000022

Patients

Seq Age Sex Outcome Treatment
1 22 YR Male Required Intervention